Medication Safety Issues
VESIcare may be confused with Vesanoid, Vessel Care (nutritional supplement)
Beers Criteria: Solifenacin is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties (Beers Criteria [AGS 2019]).
Storage/Stability
Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Adverse Reactions
>10%: Gastrointestinal: Xerostomia (11% to 28%), constipation (5% to 13%)
1% to 10%:
Cardiovascular: Hypertension (1%), lower extremity edema (1%)
Central nervous system: Fatigue (2%), depression (1%)
Gastrointestinal: Dyspepsia (4%), nausea (3%), upper abdominal pain (2%), vomiting (1%)
Genitourinary: Urinary tract infection (5%), urinary retention (1%)
Ophthalmic: Blurred vision (4% to 5%), dry eye syndrome (2%)
Respiratory: Cough (1%)
Miscellaneous: Influenza (2%)
<1%, postmarketing, and/or case reports: Abnormal hepatic function tests, anaphylaxis, angioedema, atrial fibrillation, confusion, decreased appetite, delirium, drowsiness, dry nose, dysgeusia, erythema multiforme, exfoliative dermatitis, fecal impaction, gastroesophageal reflux disease, gastrointestinal obstruction, glaucoma, hallucination, headache, hyperkalemia, hypersensitivity reaction, myastheni
